For: | Dewan B, Chimata R. An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition. World J Gastrointest Pharmacol Ther 2010; 1(5): 112-118 [PMID: 21577305 DOI: 10.4292/wjgpt.v1.i5.112] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v1/i5/112.htm |
Number | Citing Articles |
1 |
Komal Parmar, Nitisha Yagneshwari. Gastroretentive Chronopharmaceutical Formulation of Lafutidine for Early Morning Acid Breakthrough. Pharmacophore 2022; 13(5): 1 doi: 10.51847/KwfMN53pu5
|
2 |
Satish Patil, Gokul S. Talele. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability. Drug Delivery 2015; 22(3): 312 doi: 10.3109/10717544.2013.877099
|
3 |
M. Yadav, V. Trivedi, V. Upadhyay, G. Shah, H. Shah, A. Upadhyay, S. Goswami, P. S. Shrivastav. Sensitive, selective and rapid determination of lafutidine in human plasma by solid phase extraction-liquid chromatography-tandem mass spectrometry. Journal of Analytical Chemistry 2014; 69(5): 448 doi: 10.1134/S1061934814050116
|
4 |
Shihong Li, Mingzhen Xu, Huqun Li, Juan Du, Weiyong Li. Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects. Advances in Therapy 2016; 33(10): 1704 doi: 10.1007/s12325-016-0383-9
|